Brief: Tscan Therapeutics Reports Third Quarter 2022 Financial Results And Provides Business Update
09/11/2022 12:24
Nov 9 (Reuters) - Tscan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* ENDED QUARTER WITH CASH AND CASH EQUIVALENTS OF $137.3
MILLION,
FUNDING OPERATIONS INTO 2Q'24
* QTRLY LOSS PER SHARE $0.67
* Q3 EARNINGS PER SHARE VIEW $-0.72 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1hns5K
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing